Pancreatic β-cell senescence in diabetes: mechanisms, markers and therapies

Abstract

Cellular senescence is a response to a wide variety of stressors, including DNA damage, oncogene activation and physiologic aging, and pathologically accelerated senescence contributes to human disease, including diabetes mellitus. Indeed, recent work in this field has demonstrated a role for pancreatic β-cell senescence in the pathogenesis of Type 1 Diabetes, Type 2 Diabetes and monogenic diabetes. Small molecule or genetic targeting of senescent β-cells has shown promise as a novel therapeutic approach for preventing and treating diabetes. Despite these advances, major questions remain around the molecular mechanisms driving senescence in the β-cell, identification of molecular markers that distinguish senescent from non-senescent β-cell subpopulations, and translation of proof-of-concept therapies into novel treatments for diabetes in humans. Here, we summarize the current state of the field of β-cell senescence, highlighting insights from mouse models as well as studies on human islets and β-cells. We identify markers that have been used to detect β-cell senescence to unify future research efforts in this field. We discuss emerging concepts of the natural history of senescence in β-cells, heterogeneity of senescent β-cells subpopulations, role of sex differences in senescent responses, and the consequences of senescence on integrated islet function and microenvironment. As a young and developing field, there remain many open research questions which need to be addressed to move senescence-targeted approaches towards clinical investigation.

Disrupted Endoplasmic Reticulum Ca2+ Handling: A Harβinger of β-Cell Failure

“…Stressful conditions associated with diabetes reduce Ca 2+ ER stores; this elevates ER stress and initiates the unfolded protein response (UPR), which initially protects β-cells from diabetogenic stress but also limits insulin production and secretion [ 4 , 5 ]. The prolonged disruption of Ca 2+ ER can eventually lead to β-cell failure and/or senescence [ 6 ]. Importantly, alterations in the levels and/or function of the proteins involved in controlling Ca 2+ ER homeostasis can lead to diabetic phenotypes due to β-cell dysfunction.…”

Diabetes mellitus, hearing loss, and therapeutic interventions: A systematic review of insights from preclinical animal models

“…Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia [ 1 ]. In Type 1 diabetes (T1D), hyperglycemia is a result of autoimmune destruction of pancreatic beta cells leading to an absolute deficiency of insulin secretion [ 2 ].…”